Tablo Sales Boost Outset Bottom Line
Product revenues increased 5.5% and service revenues increased in Q3 of 2022 over 2021. The Tablo is used for acute and home HD, and Outset won a 5-year VA contract for Tablo in hospitals and homes.
Read the full article » | Posted 12-19-2022
Related Articles
- 30th European Nephrology Conference will be held August 27-28 in Berlin Posted 02-17-2026
- An Australian PD patient developed the free Dialysis Health Tracker app Posted 02-17-2026
- Education Critical to Boosting Home Dialysis, Panel Says I Posted 01-16-2026
- The Annual Dialysis Conference Will be in Kansas City, MO February 26 to March 1 Posted 01-16-2026

